Toyama, Japan

Shigetoshi Kadota

This inventor holds 6 USPTO granted patents. Top assignees: Kracie Pharma, Ltd., National Cancer Center, The University of Toyama. Active years: 2007-2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shigetoshi Kadota. Retrieved from https://idiyas.com/inventor/shigetoshi-kadota

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 83.3

Average Co-Inventor Count = 3.8

ph-index = 1

Forward Citations = 4(Granted Patents)


Location History:

  • Tomaya, JP (2008)
  • Toyama, JP (2007 - 2017)

Company Filing History:


Years Active: 2007-2017

Loading Chart...
6 patents (USPTO):Explore Patents

Title: Shigetoshi Kadota - Innovative Inventor from Toyama, Japan

Introduction: Shigetoshi Kadota is a renowned inventor hailing from Toyama, Japan, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Shigetoshi Kadota holds several patents in the areas of robotics, artificial intelligence, and renewable energy technologies, showcasing his versatility and forward-thinking approach to invention.

Career Highlights: With a career spanning over two decades, Kadota has worked with leading research institutions and tech companies to develop cutting-edge solutions that have revolutionized various industries.

Collaborations: Throughout his career, Shigetoshi Kadota has collaborated with top engineers, scientists, and inventors from around the world, fostering a culture of innovation and excellence in all his projects.

Conclusion: Shigetoshi Kadota's passion for innovation and his relentless pursuit of technological advancement continue to inspire the next generation of inventors and shape the future of technology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…